Brian Cogley
2023
In 2023, Brian Cogley earned a total compensation of $208K as Chief Financial Officer at Coeptis Therapeutics Holdings.
Compensation breakdown
| Bonus | $8,000 |
|---|---|
| Salary | $200,000 |
| Total | $208,000 |
Cogley received $200K in salary, accounting for 96% of the total pay in 2023.
Cogley also received $8K in bonus.
Rankings
In 2023, Brian Cogley's compensation ranked 2,736th out of 2,978 executives tracked by ExecPay. In other words, Cogley earned more than 8.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,736 out of 2,978 | 8th |
Division Manufacturing | 1,517 out of 1,637 | 7th |
Major group Chemicals And Allied Products | 851 out of 906 | 6th |
Industry group Drugs | 825 out of 869 | 5th |
Industry Biological Products, Except Diagnostic Substances | 204 out of 211 | 3rd |
Source: SEC filing on November 14, 2024.
Cogley's colleagues
We found four more compensation records of executives who worked with Brian Cogley at Coeptis Therapeutics Holdings in 2023.
2023
David Mehalick
Coeptis Therapeutics Holdings
Chief Executive Officer
2023
Daniel Yerace
Coeptis Therapeutics Holdings
Vice President of Operations
2023
Colleen Delaney
Coeptis Therapeutics Holdings
Chief Financial Officer
2023
Christine Sheehy
Coeptis Therapeutics Holdings